Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | MMP8 | P22894 | 3/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | AKT1 | P31749 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28391244 | 0.98 | ALDH1A1 (0.47) | ALDH1A1CYP3A4CYP2C9CYP2C19MMP8 | |
| SCHEMBL6803878 | 0.84 | ESR1 (0.50) | ALDH1A1CA12CA7CA9CA14 | |
| SCHEMBL21961911 | 0.84 | ALDH1A1 (0.47) | ALDH1A1CYP3A4CYP2C9CYP2C19MMP8 | |
| SCHEMBL8962483 | 0.83 | ALDH1A1 (0.44) | ALDH1A1CYP3A4CYP2C9CYP2C19MMP8 | |
| SCHEMBL868677 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CYP3A4CYP2C9CYP2C19MMP8 | |
| SCHEMBL4956054 | 0.83 | CA12 (0.50) | ALDH1A1CA12CA7CA9CA14 | |
| SCHEMBL473504 | 0.81 | CYP2C19 (0.53) | ALDH1A1CYP3A4CYP2C9CYP2C19MMP8 | |
| SCHEMBL11543629 | 0.79 | ALDH1A1 (0.49) | ALDH1A1CYP3A4CYP2C9CYP2C19MMP8 | |
| SCHEMBL10029379 | 0.79 | SMN1; SMN2 (0.44) | ALDH1A1CYP3A4CYP2C9CYP2C19MMP8 | |
| SCHEMBL17200135 | 0.78 | PTPN1 (0.46) | ALDH1A1CYP3A4CYP2C9CYP2C19MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-20030036489-A1 | Consumable composition comprising perfumed particles and article containing the same | THE PROCTER & GAMBLE COMPANY | 2003-02-20 | — | — | US | claimed |
| WO-2002090479-A1 | PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| WO-2002090481-A1 | COMPOSITIONS AND ARTICLES FOR EFFECTIVE DEPOSITION OF PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2026-04-09 | — | — | US | disclosed |
| EP-4489592-B1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2025-12-24 | — | — | EP | disclosed |
| US-20250255827-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-08-14 | — | — | US | disclosed |
| EP-4593639-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | Xampla Limited (GB) | 2025-08-06 | — | — | EP | disclosed |
| US-20250186960-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-06-12 | — | — | US | disclosed |
| EP-3888782-B1 | COATED MICROCAPSULES | NOXELL CORP (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20250177298-A1 | EMULSIONS AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-06-05 | — | — | US | disclosed |
| WO-2025109106-A1 | CORE-SHELL MICROCAPSULES | XAMPLA Ltd. (GB) | 2025-05-30 | — | — | WO | disclosed |
| WO-2002090479-A1 | PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | disclosed |
| WO-2002089862-A2 | AIR FRESHENING COMPOSITIONS, ARTICLES COMPRISING SAME AND METHODS FOR PREPARING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | disclosed |
| CN-1261786-A | Ferfumed compositions and method for reducing body odors and excess moisture | PROCTER & GAMBLE (US) | 2000-08-02 | — | — | CN | disclosed |
| EP-0988025-A1 | PERFUMED COMPOSITIONS AND METHODS FOR REDUCING BODY ODORS AND EXCESS MOISTURE | THE PROCTER & GAMBLE COMPANY (US) | 2000-03-29 | — | — | EP | disclosed |
| US-5861144-A | UNCOMPLEXED CYCLODEXTRIN, PERFUME, MOISTURE ABSORBER, POWDER CARRIER | THE PROCTER & GAMBLE COMPANY (US) | 1999-01-19 | — | — | US | disclosed |
| US-5861146-A | APPLYING MIXTURES CONTAINING UNCOMPLEXED CYCLODEXTRINS, PERFUMES(BOTH FREE AND ENCAPSULATED), ADJUVANTS AND POWDERED CARRIERS TO SKIN | THE PROCTER & GAMBLE COMPANY (US) | 1999-01-19 | — | — | US | disclosed |
| US-5861143-A | DRYING AND DEODORIZING SKIN WITH CYCLODEXTRIN AND PERFUMES | THE PROCTER & GAMBLE COMPANY (US) | 1999-01-19 | — | — | US | disclosed |
| WO-1998056340-A1 | PERFUMED COMPOSITIONS AND METHODS FOR REDUCING BODY ODORS AND EXCESS MOISTURE | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | PCTP, CLK4, MTCL3 | ALDH1A1 4813/4885CYP3A4 4797/4885CYP2C9 4704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.